What a test can show
Pharmacogenetic genotype translated into a functional phenotype.
Pharmacogenomics
SLCO1B1Statins and muscle adverse effects
Transporter function affects exposure to some statins and risk of muscle symptoms.
RELATIONSHIP VALIDITYCPIC clinical guideline
ACTIONABILITYContextual: drug- and dose-specific
SOURCE CHECKLinks and claim boundaries are editorially checked; external expert review is stated only with named disclosure
Practical meaning
A result may help a clinician individualise statin choice or dose.
Where knowledge ends
It does not explain all muscle symptoms or replace assessment of drug interactions.
SOURCES AND VERSION
Verifiable, not ‘trust us’.
Updated: 14 August 2026. Any clinical interpretation requires the exact variant, testing method, family information and medical context.